Projected Stock Price
Estimated share price by August 22, 2026.
Projected Revenue
No data available.
Projected Earnings Per Share
Estimated quarterly earnings by December 31, 2027.
Price Target
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Arista Networks Inc - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2025-04-15 | Evercore ISI Group | Outperform | Outperform | Maintains |
2025-04-14 | Citigroup | Buy | Buy | Maintains |
2025-04-22 | Rosenblatt | Sell | Sell | Maintains |
2025-06-26 | Keybanc | Overweight | Initiate | |
2025-03-05 | UBS | Neutral | Buy | Upgrade |
2025-02-19 | Wells Fargo | Overweight | Overweight | Maintains |
2025-02-19 | UBS | Neutral | Neutral | Maintains |
2025-02-19 | Rosenblatt | Sell | Sell | Maintains |
2025-02-19 | Piper Sandler | Neutral | Neutral | Reiterate |
2025-02-19 | Needham | Buy | Buy | Reiterate |
2025-02-19 | Citigroup | Buy | Buy | Maintains |
2025-02-19 | Barclays | Overweight | Overweight | Maintains |
2025-02-19 | Goldman Sachs | Buy | Buy | Maintains |
2025-02-18 | Rosenblatt | Sell | Sell | Maintains |
2025-01-17 | Goldman Sachs | Buy | Buy | Maintains |
2025-01-17 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-12-17 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-12-04 | Barclays | Overweight | Overweight | Maintains |
2024-11-08 | Rosenblatt | Sell | Sell | Maintains |
2024-11-08 | UBS | Neutral | Neutral | Maintains |
2024-11-08 | Barclays | Overweight | Overweight | Maintains |
2024-11-08 | Piper Sandler | Neutral | Neutral | Reiterate |
2024-10-30 | Wells Fargo | Overweight | Overweight | Maintains |
2024-10-08 | Citigroup | Buy | Buy | Maintains |
2024-10-01 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-09-24 | Goldman Sachs | Buy | Buy | Maintains |
2024-09-13 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-09-04 | UBS | Neutral | Neutral | Maintains |
2024-07-31 | Rosenblatt | Sell | Sell | Maintains |
2024-07-31 | JP Morgan | Overweight | Overweight | Maintains |
2024-07-31 | Barclays | Overweight | Overweight | Maintains |
2024-07-31 | Jefferies | Buy | Buy | Maintains |
2024-07-31 | Needham | Buy | Buy | Reiterate |
2024-07-24 | Wells Fargo | Overweight | Overweight | Maintains |
2024-07-18 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-07-17 | Keybanc | Overweight | Overweight | Maintains |
2024-07-16 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-07-15 | Piper Sandler | Neutral | Neutral | Maintains |
2024-06-27 | Citigroup | Buy | Buy | Maintains |
2024-06-20 | B of A Securities | Buy | Buy | Maintains |
2024-06-14 | Erste Group | Buy | Reiterate | |
2024-06-12 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-05-20 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-05-09 | Barclays | Overweight | Overweight | Maintains |
2024-05-08 | Wells Fargo | Overweight | Overweight | Maintains |
2024-05-08 | Piper Sandler | Neutral | Neutral | Maintains |
2024-05-08 | Keybanc | Overweight | Overweight | Maintains |
2024-05-08 | UBS | Neutral | Neutral | Maintains |
2024-05-08 | Needham | Buy | Buy | Reiterate |
2024-05-03 | Jefferies | Hold | Buy | Upgrade |
2024-04-12 | Rosenblatt | Buy | Sell | Downgrade |
2024-04-11 | JP Morgan | Overweight | Overweight | Maintains |
2024-03-27 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-03-22 | Goldman Sachs | Buy | Buy | Maintains |
2024-02-13 | Piper Sandler | Neutral | Neutral | Maintains |
2024-02-13 | Oppenheimer | Perform | Perform | Maintains |
2024-02-13 | Goldman Sachs | Buy | Buy | Maintains |
2024-02-13 | Rosenblatt | Buy | Buy | Maintains |
2024-02-13 | Barclays | Overweight | Overweight | Maintains |
2024-02-13 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
2024-02-13 | Needham | Buy | Buy | Reiterate |
2024-02-07 | Wells Fargo | Overweight | Overweight | Maintains |
2024-02-05 | JMP Securities | Market Outperform | Market Outperform | Maintains |
2024-01-22 | Keybanc | Overweight | Overweight | Maintains |
2024-01-18 | Keybanc | Overweight | Overweight | Maintains |
2024-01-08 | Melius Research | Hold | Buy | Upgrade |
2024-01-02 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-11-10 | Piper Sandler | Neutral | Neutral | Maintains |
2023-11-10 | Goldman Sachs | Buy | Buy | Maintains |
2023-11-10 | Needham | Buy | Buy | Maintains |
2023-10-31 | JMP Securities | Market Outperform | Market Outperform | Maintains |
2023-10-31 | Needham | Buy | Buy | Maintains |
2023-10-31 | Keybanc | Overweight | Overweight | Maintains |
2023-10-31 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2023-10-11 | Piper Sandler | Overweight | Neutral | Downgrade |
2023-09-14 | Rosenblatt | Buy | Buy | Maintains |
2023-09-13 | B of A Securities | Buy | Buy | Maintains |
2023-08-31 | Citigroup | Neutral | Buy | Upgrade |
2023-08-02 | Argus Research | Buy | Buy | Maintains |
2023-08-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-08-01 | Citigroup | Neutral | Neutral | Maintains |
2023-08-01 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
2023-08-01 | Goldman Sachs | Buy | Buy | Maintains |
2023-08-01 | Wells Fargo | Overweight | Overweight | Maintains |
2023-08-01 | Rosenblatt | Buy | Buy | Maintains |
2023-08-01 | Barclays | Overweight | Overweight | Maintains |
2023-08-01 | Piper Sandler | Overweight | Overweight | Maintains |
2023-08-01 | Keybanc | Overweight | Overweight | Maintains |
2023-08-01 | Needham | Buy | Buy | Maintains |
2023-07-26 | JMP Securities | Market Outperform | Market Outperform | Maintains |
2023-07-26 | Rosenblatt | Buy | Buy | Reiterate |
2023-07-21 | Keybanc | Overweight | Overweight | Maintains |
2023-07-20 | Exane BNP Paribas | Outperform | Initiate | |
2023-07-17 | Evercore ISI Group | Outperform | Outperform | Reiterate |
2023-06-30 | Citigroup | Neutral | Initiate | |
2023-05-02 | Argus Research | Buy | Maintains | |
2023-05-02 | JMP Securities | Market Outperform | Reiterate | |
2023-05-02 | Piper Sandler | Overweight | Maintains | |
2023-05-02 | Needham | Buy | Reiterate | |
2023-05-02 | Credit Suisse | Neutral | Maintains | |
2023-05-02 | Barclays | Overweight | Maintains | |
2023-04-19 | JP Morgan | Overweight | Maintains | |
2023-04-14 | Morgan Stanley | Equal-Weight | Maintains | |
2023-04-05 | Rosenblatt | Buy | Reiterate | |
2023-04-05 | Goldman Sachs | Buy | Maintains | |
2023-03-22 | Wells Fargo | Overweight | Maintains | |
2023-03-07 | Goldman Sachs | Buy | Initiate | |
2023-02-14 | Cowen & Co. | Outperform | Maintains | |
2023-02-14 | Wells Fargo | Overweight | Maintains | |
2023-02-14 | Loop Capital | Buy | Maintains | |
2023-02-14 | Morgan Stanley | Equal-Weight | Maintains | |
2023-02-14 | Credit Suisse | Neutral | Maintains | |
2023-02-14 | Rosenblatt | Buy | Reiterate | |
2023-02-14 | Needham | Buy | Maintains | |
2023-02-14 | JMP Securities | Market Outperform | Maintains | |
2023-02-14 | Barclays | Overweight | Maintains | |
2023-01-17 | Piper Sandler | Overweight | Maintains | |
2022-12-13 | Cowen & Co. | Outperform | Maintains | |
2022-11-21 | Rosenblatt | Buy | Maintains | |
2022-11-07 | Morgan Stanley | Equal-Weight | Maintains | |
2022-11-07 | Credit Suisse | Neutral | Maintains | |
2022-11-04 | Needham | Buy | Maintains | |
2022-11-04 | Piper Sandler | Neutral | Overweight | Upgrade |
2022-11-01 | B of A Securities | Underperform | Buy | Upgrade |
2022-11-01 | Rosenblatt | Buy | Maintains | |
2022-11-01 | Cowen & Co. | Outperform | Maintains | |
2022-11-01 | Credit Suisse | Neutral | Maintains | |
2022-11-01 | Barclays | Overweight | Maintains | |
2022-11-01 | Keybanc | Overweight | Maintains | |
2022-10-25 | Credit Suisse | Outperform | Neutral | Downgrade |
2022-10-18 | Piper Sandler | Neutral | Maintains | |
2022-10-11 | Morgan Stanley | Equal-Weight | Maintains | |
2022-09-22 | Barclays | Equal-Weight | Overweight | Upgrade |
2022-09-21 | Barclays | Equal-Weight | Overweight | Upgrade |
2022-08-24 | Deutsche Bank | Hold | Initiate | |
2022-08-02 | UBS | Neutral | Maintains | |
2022-08-02 | Cowen & Co. | Outperform | Maintains | |
2022-08-02 | Evercore ISI Group | Outperform | Maintains | |
2022-08-02 | Rosenblatt | Buy | Maintains | |
2022-08-02 | Citigroup | Buy | Maintains | |
2022-08-02 | JP Morgan | Overweight | Maintains | |
2022-08-02 | Barclays | Equal-Weight | Maintains | |
2022-08-02 | Morgan Stanley | Equal-Weight | Maintains | |
2022-08-02 | Needham | Buy | Maintains | |
2022-08-02 | Piper Sandler | Neutral | Maintains | |
2022-08-02 | Credit Suisse | Outperform | Maintains | |
2022-07-20 | B of A Securities | Buy | Underperform | Downgrade |
2022-07-19 | Needham | Hold | Buy | Upgrade |
2022-07-14 | JP Morgan | Overweight | Maintains | |
2022-07-13 | Piper Sandler | Neutral | Maintains | |
2022-07-13 | Rosenblatt | Buy | Initiate | |
2022-06-28 | Evercore ISI Group | Outperform | Maintains | |
2022-06-14 | Morgan Stanley | Equal-Weight | Maintains | |
2022-05-03 | Credit Suisse | Outperform | Maintains | |
2022-05-03 | Barclays | Equal-Weight | Maintains | |
2022-05-03 | Piper Sandler | Neutral | Maintains | |
2022-05-03 | Keybanc | Overweight | Maintains | |
2022-03-10 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
2022-02-15 | Morgan Stanley | Equal-Weight | Maintains | |
2022-02-15 | Wells Fargo | Equal-Weight | Maintains | |
2022-02-15 | Barclays | Equal-Weight | Maintains | |
2022-02-15 | Citigroup | Buy | Maintains | |
2022-02-15 | Piper Sandler | Neutral | Maintains | |
2022-02-15 | Credit Suisse | Outperform | Maintains | |
2022-02-15 | Keybanc | Overweight | Maintains | |
2022-02-14 | Loop Capital | Buy | Initiate | |
2022-01-24 | Citigroup | Neutral | Buy | Upgrade |
2022-01-19 | Keybanc | Overweight | Maintains | |
2021-12-22 | Citigroup | Neutral | Maintains | |
2021-12-17 | Cleveland Research | Neutral | Buy | Upgrade |
2021-11-29 | Keybanc | Overweight | Maintains | |
2021-11-19 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2021-11-18 | Morgan Stanley | Overweight | Maintains | |
2021-11-16 | UBS | Buy | Neutral | Downgrade |
2021-11-02 | Piper Sandler | Neutral | Maintains | |
2021-11-02 | Morgan Stanley | Overweight | Maintains | |
2021-11-02 | Barclays | Equal-Weight | Maintains | |
2021-11-02 | Credit Suisse | Outperform | Maintains | |
2021-11-02 | Wells Fargo | Equal-Weight | Maintains | |
2021-11-02 | JMP Securities | Market Outperform | Maintains | |
2021-08-04 | Argus Research | Buy | Maintains | |
2021-08-03 | MKM Partners | Buy | Maintains | |
2021-08-03 | Evercore ISI Group | Outperform | Maintains | |
2021-08-03 | Citigroup | Neutral | Maintains | |
2021-08-03 | Barclays | Equal-Weight | Maintains | |
2021-08-03 | Credit Suisse | Outperform | Maintains | |
2021-08-03 | Wells Fargo | Equal-Weight | Maintains | |
2021-08-03 | Piper Sandler | Neutral | Maintains | |
2021-08-03 | Keybanc | Overweight | Maintains | |
2021-07-27 | JMP Securities | Market Outperform | Maintains | |
2021-07-22 | Keybanc | Overweight | Maintains | |
2021-07-06 | Morgan Stanley | Overweight | Maintains | |
2021-05-05 | Credit Suisse | Outperform | Maintains | |
2021-05-05 | Keybanc | Overweight | Maintains | |
2021-04-23 | Keybanc | Overweight | Reiterate | |
2021-02-22 | Morgan Stanley | Overweight | Maintains | |
2021-02-19 | Wells Fargo | Equal-Weight | Maintains | |
2021-02-19 | Morgan Stanley | Overweight | Maintains | |
2021-02-19 | Goldman Sachs | Buy | Maintains | |
2021-02-19 | Credit Suisse | Outperform | Maintains | |
2021-02-19 | Rosenblatt | Buy | Maintains | |
2021-02-19 | Barclays | Equal-Weight | Maintains | |
2021-01-25 | JP Morgan | Overweight | Maintains | |
2021-01-25 | Rosenblatt | Buy | Maintains | |
2021-01-14 | Barclays | Equal-Weight | Maintains | |
2021-01-07 | Rosenblatt | Neutral | Buy | Upgrade |
2021-01-06 | Credit Suisse | Neutral | Outperform | Upgrade |
2020-12-15 | Morgan Stanley | Overweight | Maintains | |
2020-11-18 | Evercore ISI Group | In-Line | Outperform | Upgrade |
2020-11-03 | Credit Suisse | Neutral | Maintains | |
2020-11-03 | Rosenblatt | Neutral | Maintains | |
2020-11-03 | B of A Securities | Neutral | Buy | Upgrade |
2020-10-30 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2020-10-12 | Citigroup | Buy | Neutral | Downgrade |
2020-10-08 | JP Morgan | Neutral | Overweight | Upgrade |
2020-09-23 | UBS | Buy | Initiate | |
2020-09-11 | MKM Partners | Neutral | Maintains | |
2020-08-06 | Citigroup | Buy | Maintains | |
2020-08-05 | Morgan Stanley | Equal-Weight | Maintains | |
2020-08-05 | Rosenblatt | Neutral | Maintains | |
2020-07-24 | Rosenblatt | Neutral | Maintains | |
2020-07-21 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-06 | Nomura Instinet | Neutral | Maintains | |
2020-05-06 | B of A Securities | Neutral | Reiterate | |
2020-05-06 | Credit Suisse | Neutral | Maintains | |
2020-05-06 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-06 | Citigroup | Buy | Maintains | |
2020-04-09 | Piper Sandler | Overweight | Neutral | Downgrade |
2020-03-19 | Morgan Stanley | Equal-Weight | Maintains | |
2020-03-13 | Nomura | Neutral | Maintains | |
2020-03-04 | JP Morgan | Underweight | Neutral | Upgrade |
2020-02-18 | Argus Research | Buy | Reiterate | |
2020-02-14 | MKM Partners | Neutral | Maintains | |
2020-02-14 | Morgan Stanley | Equal-Weight | Maintains | |
2020-02-14 | Rosenblatt | Neutral | Maintains | |
2020-01-30 | Barclays | Overweight | Equal-Weight | Downgrade |
2019-11-19 | New Street Research | Buy | Initiate | |
2019-11-04 | UBS | Neutral | Maintains | |
2019-11-01 | KeyBanc | Overweight | Sector Weight | Downgrade |
2019-11-01 | Stifel Nicolaus | Buy | Hold | Downgrade |
2019-11-01 | Bank of America | Buy | Neutral | Downgrade |
2019-11-01 | Wells Fargo | Market Perform | Maintains | |
2019-11-01 | Needham | Buy | Hold | Downgrade |
2019-11-01 | Citigroup | Buy | Maintains | |
2019-11-01 | Deutsche Bank | Hold | Maintains | |
2019-11-01 | Piper Jaffray | Overweight | Maintains | |
2019-11-01 | JP Morgan | Neutral | Underweight | Downgrade |
2019-11-01 | Nomura | Neutral | Maintains | |
2019-11-01 | MKM Partners | Neutral | Maintains | |
2019-11-01 | JMP Securities | Market Outperform | Maintains | |
2019-11-01 | Oppenheimer | Outperform | Perform | Downgrade |
2019-11-01 | Morgan Stanley | Equal-Weight | Maintains | |
2019-11-01 | Goldman Sachs | Buy | Maintains | |
2019-10-03 | Nomura | Buy | Neutral | Downgrade |
2019-09-11 | Evercore ISI Group | In-Line | Initiate | |
2019-08-08 | Barclays | Overweight | Initiate | |
2019-06-07 | Morgan Stanley | Equal-Weight | Maintains | |
2019-05-03 | Stifel Nicolaus | Buy | Buy | Maintains |
2019-04-26 | Nomura | Buy | Buy | Maintains |
2019-04-23 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2019-04-18 | KeyBanc | Overweight | Overweight | Maintains |
2019-03-29 | Rosenblatt | Neutral | Initiate | |
2019-03-21 | Goldman Sachs | Buy | Reiterate | |
2019-03-20 | Deutsche Bank | Sell | Hold | Upgrade |
2019-03-07 | Morgan Stanley | Overweight | Overweight | Maintains |
2019-01-18 | Nomura | Neutral | Buy | Upgrade |
2019-01-07 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2018-12-06 | Bank of America | Neutral | Buy | Upgrade |
2018-11-02 | Citigroup | Buy | Buy | Maintains |
2018-11-02 | BMO Capital | Outperform | Outperform | Maintains |
2018-11-02 | KeyBanc | Overweight | Overweight | Maintains |
2018-11-02 | JP Morgan | Neutral | Neutral | Maintains |
2018-11-02 | Nomura | Neutral | Neutral | Maintains |
2018-10-23 | Stifel Nicolaus | Buy | Initiate | |
2018-10-17 | BMO Capital | Market Perform | Outperform | Upgrade |
2018-10-04 | Credit Suisse | Outperform | Outperform | Maintains |
2018-09-26 | UBS | Neutral | Initiate | |
2018-09-04 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2018-07-23 | JP Morgan | Neutral | Neutral | Maintains |
2018-07-09 | PiperJaffray | Neutral | Overweight | Upgrade |
2018-05-10 | Credit Suisse | Outperform | Initiate | |
2018-05-04 | Deutsche Bank | Sell | Sell | Maintains |
2018-05-04 | Citigroup | Buy | Buy | Maintains |
2018-05-04 | KeyBanc | Overweight | Overweight | Maintains |
2018-05-03 | JP Morgan | Neutral | Initiate | |
2018-05-01 | Macquarie | Outperform | Initiate | |
2018-03-19 | Deutsche Bank | Hold | Sell | Downgrade |
2018-03-09 | Citigroup | Buy | Buy | Maintains |
2018-02-20 | Nomura | Neutral | Neutral | Maintains |
2018-02-16 | Gabelli & Co. | Buy | Hold | Downgrade |
2018-02-15 | Barclays | Overweight | Overweight | Maintains |
2018-02-07 | Goldman Sachs | Buy | Initiate | |
2018-01-30 | Loop Capital | Hold | Initiate | |
2018-01-26 | JMP Securities | Market Perform | Market Perform | Maintains |
2018-01-24 | Citigroup | Neutral | Buy | Maintains |
2018-01-23 | Deutsche Bank | Buy | Hold | Downgrade |
2017-11-13 | PiperJaffray | Neutral | Initiate | |
2017-11-03 | Citigroup | Neutral | Maintains | |
2017-11-03 | UBS | Neutral | Maintains | |
2017-11-03 | BMO Capital | Market Perform | Maintains | |
2017-11-03 | Jefferies | Hold | Maintains | |
2017-11-03 | Nomura | Neutral | Maintains | |
2017-11-03 | DA Davidson | Neutral | Buy | Upgrade |
2017-10-26 | JMP Securities | Market Perform | Maintains | |
2017-09-28 | BMO Capital | Outperform | Market Perform | Downgrade |
2017-09-26 | Berenberg | Buy | Initiate | |
2017-09-20 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2017-08-04 | William Blair | Market Perform | Outperform | Upgrade |
2017-08-04 | JP Morgan | Neutral | Overweight | Upgrade |
2017-08-04 | Barclays | Overweight | Maintains | |
2017-05-22 | DA Davidson | Buy | Neutral | Downgrade |
2017-04-27 | Credit Suisse | Outperform | Neutral | Downgrade |
2017-04-07 | Nomura | Buy | Neutral | Downgrade |
2017-04-03 | Stifel Nicolaus | Buy | Hold | Downgrade |
2017-02-17 | Jefferies | Underperform | Hold | Upgrade |
2017-01-25 | DA Davidson | Buy | Initiate | |
2016-12-05 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2016-11-23 | Deutsche Bank | Buy | Maintains | |
2016-11-22 | Pacific Crest | Overweight | Maintains | |
2016-10-25 | Argus | Buy | Initiate | |
2016-10-25 | Argus Research | Buy | Initiate | |
2016-09-19 | MKM Partners | Buy | Neutral | Downgrade |
2016-09-14 | Deutsche Bank | Buy | Maintains | |
2016-08-26 | Citigroup | Neutral | Maintains | |
2016-08-18 | BMO Capital | Outperform | Initiate | |
2016-08-05 | UBS | Neutral | Maintains | |
2016-05-13 | JP Morgan | Neutral | Initiate | |
2016-02-19 | Deutsche Bank | Buy | Maintains | |
2016-02-01 | Deutsche Bank | Buy | Maintains | |
2016-01-27 | Citigroup | Buy | Initiate | |
2016-01-06 | JP Morgan | Neutral | Initiate | |
2016-01-04 | Oppenheimer | Perform | Outperform | Upgrade |
2015-11-06 | Deutsche Bank | Buy | Maintains | |
2015-10-14 | Barclays | Overweight | Initiate | |
2015-09-16 | Buckingham Research | Neutral | Maintains | |
2015-08-07 | Pacific Crest | Overweight | Maintains | |
2015-08-04 | Macquarie | Neutral | Initiate | |
2015-08-03 | Macquarie | Neutral | Initiate | |
2015-07-29 | KeyBanc | Overweight | Maintains | |
2015-06-26 | MKM Partners | Buy | Maintains | |
2015-06-24 | Needham | Buy | Maintains | |
2015-06-22 | Deutsche Bank | Buy | Maintains | |
2015-06-17 | Sterne Agee CRT | Buy | Initiate | |
2015-06-08 | Guggenheim | Neutral | Buy | Upgrade |
2015-06-05 | Pacific Crest | Overweight | Maintains | |
2015-06-05 | KeyBanc | Overweight | Maintains | |
2015-06-03 | Nomura | Buy | Initiate | |
2015-04-09 | Wedbush | Neutral | Initiate | |
2015-03-26 | Guggenheim | Neutral | Initiate | |
2015-02-20 | Deutsche Bank | Buy | Maintains | |
2015-02-20 | Barclays | Overweight | Maintains | |
2015-02-04 | Citigroup | Buy | Neutral | Downgrade |
2015-01-16 | Buckingham Research | Neutral | Initiate | |
2014-12-09 | Deutsche Bank | Buy | Maintains | |
2014-12-08 | Citigroup | Buy | Maintains | |
2014-12-01 | Jefferies | Underperform | Initiate | |
2014-11-07 | Barclays | Overweight | Maintains | |
2014-11-05 | Imperial Capital | Outperform | Initiate | |
2014-11-03 | Stifel Nicolaus | Hold | Buy | Upgrade |
2014-10-08 | MKM Partners | Buy | Initiate | |
2014-09-10 | Deutsche Bank | Buy | Maintains | |
2014-09-08 | FBN Securities | Outperform | Initiate | |
2014-09-02 | SunTrust Robinson Humphrey | Buy | Initiate | |
2014-08-08 | Citigroup | Neutral | Buy | Upgrade |
2014-08-08 | Pacific Crest | Outperform | Maintains | |
2014-08-08 | JP Morgan | Buy | Maintains | |
2014-08-06 | Deutsche Bank | Buy | Maintains | |
2014-07-01 | Oppenheimer | Market Perform | Initiate | |
2014-07-01 | Cowen & Co. | Outperform | Initiate | |
2014-07-01 | Wells Fargo | Outperform | Initiate | |
2014-07-01 | Deutsche Bank | Buy | Initiate | |
2014-07-01 | JMP Securities | Market Perform | Initiate | |
2014-07-01 | RBC Capital | Outperform | Initiate | |
2014-07-01 | Morgan Stanley | Overweight | Initiate | |
2014-07-01 | Barclays | Overweight | Initiate | |
2014-07-01 | Raymond James | Market Perform | Initiate | |
2014-07-01 | Needham | Buy | Initiate | |
2014-07-01 | Stifel Nicolaus | Hold | Initiate | |
2014-07-01 | William Blair | Market Perform | Initiate | |
2025-04-08 | Piper Sandler | Neutral | Neutral | Maintains |
2025-04-29 | Rosenblatt | Sell | Neutral | Upgrade |
2025-05-07 | Goldman Sachs | Buy | Buy | Maintains |
2025-05-07 | Citigroup | Buy | Buy | Maintains |
2025-05-07 | Piper Sandler | Neutral | Neutral | Reiterate |
2025-05-07 | Rosenblatt | Neutral | Neutral | Maintains |
2025-05-07 | Needham | Buy | Buy | Maintains |
2025-09-03 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-07-31 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-04-08 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-04-17 | JP Morgan | Overweight | Overweight | Maintains |
2025-07-17 | JP Morgan | Overweight | Overweight | Maintains |
2025-05-08 | Barclays | Overweight | Overweight | Maintains |
2025-08-06 | Goldman Sachs | Buy | Buy | Maintains |
2025-08-06 | UBS | Buy | Buy | Maintains |
2025-08-06 | Evercore ISI Group | Outperform | Outperform | Maintains |
2025-08-06 | Keybanc | Overweight | Overweight | Maintains |
2025-08-06 | Needham | Buy | Buy | Maintains |
2025-05-15 | Needham | Buy | Buy | Reiterate |
2025-05-01 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-05-13 | Citigroup | Buy | Buy | Maintains |
2025-05-28 | Redburn Atlantic | Buy | Initiate | |
2025-07-11 | Citigroup | Buy | Buy | Maintains |
2025-06-23 | Evercore ISI Group | Outperform | Outperform | Maintains |
2025-08-07 | Barclays | Overweight | Overweight | Maintains |
2025-08-06 | Rosenblatt | Neutral | Neutral | Maintains |
2025-08-06 | Citigroup | Buy | Buy | Maintains |
2025-08-06 | JP Morgan | Overweight | Overweight | Maintains |
2025-08-06 | Piper Sandler | Neutral | Neutral | Maintains |
2025-08-06 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-07-08 | Wolfe Research | Outperform | Initiate |
Revenue Estimates
No data available.
Earnings Estimates
The forecasted annual earnings of Arista Networks Inc - Depositary Receipt (Common Stock) in 2029-12-31 is 4.94 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 0.65 | 19 | -- | -- |
2025-12-31 | 0.68 | 19 | 2.53 | 28 |
2026-03-31 | 0.67 | 13 | -- | -- |
2026-06-30 | 0.70 | 13 | -- | -- |
2026-09-30 | 0.75 | 13 | -- | -- |
2026-12-31 | 0.79 | 13 | 2.96 | 27 |
2027-03-31 | 0.82 | 5 | -- | -- |
2027-06-30 | 0.86 | 5 | -- | -- |
2027-09-30 | 0.92 | 5 | -- | -- |
2027-12-31 | 0.95 | 5 | 3.65 | 10 |
2028-12-31 | -- | -- | 4.27 | 3 |
2029-12-31 | -- | -- | 4.94 | 3 |